In addition, ADAR1-mediated hyperediting antizyme inhibitor 1 (AZIN1), which is capable of influencing self-renewal and differentiation at the stem cell level, has been discovered in hepatocellular carcinoma (HCC) and colorectal and gastric cancers [109, 112–114]. Here, AZIN1 is linked to hepatocellular carcinoma.